Ah ok - that is wonderful news. I have asked this on the forum many times and it seems to not be the done thing but if they are saying it, they must have received some indication from the FDA that they are open to it - can't imagine Jon disclosing it otherwise.
That is truly wonderful - if we get through the P3 PMS trial with flying colours, then we are looking at stratospheric valuations, as the business model is so commercially simple and predictable.
Wow - would be massive if that was approved.
NEU Price at posting:
$13.73 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)